Saptomycin D is a natural product belonging to the class of antibiotics known as aminoglycosides, which are primarily derived from microbial sources. It exhibits a complex structure characterized by multiple functional groups that contribute to its biological activity. Saptomycin D is known for its potent antibacterial properties, particularly against Gram-positive bacteria, making it a subject of interest in the development of new antimicrobial agents. The compound's mechanism of action typically involves inhibiting protein synthesis by binding to the bacterial ribosome, thereby disrupting essential cellular processes. Additionally, saptomycin D may exhibit varying degrees of cytotoxicity, which is an important consideration in its therapeutic application. Its solubility, stability, and pharmacokinetic properties are also critical factors that influence its efficacy and safety profile. Research into saptomycin D continues to explore its potential uses in treating resistant bacterial infections and its role in the broader context of antibiotic discovery and development.

Saptomycin D is a compound with antimicrobial and antitumor activities.

saptomycin D

137714-91-1: Saptomycin D is a natural product belonging to the class of antibiotics known as aminoglycosides, which are primarily derived from microbial sources. It exhibits a complex structure characterized by multiple functional groups that contribute to its biological activity. Saptomycin D is known for its potent antibacterial properties, particularly against Gram-positive bacteria, making it a subject of interest in the development of new antimicrobial agents. The compound's mechanism of action typically involves inhibiting protein synthesis by binding to the bacterial ribosome, thereby disrupting essential cellular processes. Additionally, saptomycin D may exhibit varying degrees of cytotoxicity, which is an important consideration in its therapeutic application. Its solubility, stability, and pharmacokinetic properties are also critical factors that influence its efficacy and safety profile. Research into saptomycin D continues to explore its potential uses in treating resistant bacterial infections and its role in the broader context of antibiotic discovery and development.

<p>Saptomycin D, an antibiotic (antibiotic) isolated from the Streptomyces sp. HP530 strain, exhibits potent antitumor activity. It demonstrates strong inhibitory effects on Gram-positive bacteria and weaker inhibition against certain Gram-negative bacteria and yeasts. Additionally, Saptomycin D shows significant antitumor properties that make it a candidate for research in cancer therapy.</p>

CAS 137714-91-1

saptomycin D

Saptomycin D

Ref: TM-TN8020